イタリア -
イタリア語 -
AIFA (Agenzia Italiana del Farmaco)
plavix
bb farma s.r.l. - clopidogrel - clopidogrel
イタリア -
イタリア語 -
AIFA (Agenzia Italiana del Farmaco)
plavix
programmi sanitari integrati s.r.l. - clopidogrel - clopidogrel
イタリア -
イタリア語 -
AIFA (Agenzia Italiana del Farmaco)
plavix
difarmed sociedad limitada - clopidogrel - clopidogrel
イタリア -
イタリア語 -
AIFA (Agenzia Italiana del Farmaco)
plavix
farma 1000 s.r.l. - clopidogrel - clopidogrel
イタリア -
イタリア語 -
AIFA (Agenzia Italiana del Farmaco)
plavix
gmm farma s.r.l. - clopidogrel - clopidogrel
イタリア -
イタリア語 -
AIFA (Agenzia Italiana del Farmaco)
plavix
new pharmashop s.r.l. - clopidogrel - clopidogrel
欧州連合 -
イタリア語 -
EMA (European Medicines Agency)
zeposia
bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunosoppressori - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
